{"entity":{"type":"insider","cik":"0001658379","url":"/insider/0001658379","json_url":"/insider/0001658379.json","name":"Coleman Mark","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":23,"n_filings":14,"first":"2019-03-21","last":"2026-06-10","span_basis":"filed_date"},"name_variants":[{"name":"Coleman Mark","source":"filing","n_filings":14,"first_seen":"2019-03-21","last_seen":"2026-06-10"}],"transactions":[{"id":6234674,"accession":"0001193125-26-266433","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-26-266433","line_url":"/filing/0001193125-26-266433#line-2","is_derivative":false,"issuer_cik":"0001579428","issuer_name":"Axsome Therapeutics, Inc.","issuer_ticker":"AXSM","issuer_name_source":null,"issuer_url":"/issuer/0001579428","owner_cik":"0001658379","owner_name":"Coleman Mark","owner_url":"/insider/0001658379","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":643.0,"shares_display":"643","price_per_share":249.0,"price_display":"249.00","price_state":"stated","total_value":160107.0,"total_display":"160,107.00","shares_owned_after":30389.0,"shares_owned_after_display":"30,389","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-10","filed_date":"2026-06-10","scope":"insider"},{"id":6088647,"accession":"0001193125-26-254038","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001193125-26-254038","line_url":"/filing/0001193125-26-254038#line-3","is_derivative":false,"issuer_cik":"0001579428","issuer_name":"Axsome Therapeutics, Inc.","issuer_ticker":"AXSM","issuer_name_source":null,"issuer_url":"/issuer/0001579428","owner_cik":"0001658379","owner_name":"Coleman Mark","owner_url":"/insider/0001658379","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5537.0,"shares_display":"5,537","price_per_share":223.39,"price_display":"223.39","price_state":"stated","total_value":1236910.43,"total_display":"1,236,910.43","shares_owned_after":29603.0,"shares_owned_after_display":"29,603","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-02","filed_date":"2026-06-02","scope":"insider"},{"id":6088643,"accession":"0001193125-26-254038","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-26-254038","line_url":"/filing/0001193125-26-254038#line-2","is_derivative":false,"issuer_cik":"0001579428","issuer_name":"Axsome Therapeutics, Inc.","issuer_ticker":"AXSM","issuer_name_source":null,"issuer_url":"/issuer/0001579428","owner_cik":"0001658379","owner_name":"Coleman Mark","owner_url":"/insider/0001658379","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6000.0,"shares_display":"6,000","price_per_share":230.3,"price_display":"230.30","price_state":"stated","total_value":1381800.0,"total_display":"1,381,800.00","shares_owned_after":35140.0,"shares_owned_after_display":"35,140","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-01","filed_date":"2026-06-02","scope":"insider"},{"id":6088640,"accession":"0001193125-26-254038","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-254038","line_url":"/filing/0001193125-26-254038#line-1","is_derivative":false,"issuer_cik":"0001579428","issuer_name":"Axsome Therapeutics, Inc.","issuer_ticker":"AXSM","issuer_name_source":null,"issuer_url":"/issuer/0001579428","owner_cik":"0001658379","owner_name":"Coleman Mark","owner_url":"/insider/0001658379","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6000.0,"shares_display":"6,000","price_per_share":233.46,"price_display":"233.46","price_state":"stated","total_value":1400760.0,"total_display":"1,400,760.00","shares_owned_after":41140.0,"shares_owned_after_display":"41,140","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-29","filed_date":"2026-06-02","scope":"insider"},{"id":6072855,"accession":"0001193125-26-083587","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-083587","line_url":"/filing/0001193125-26-083587#line-1","is_derivative":false,"issuer_cik":"0001579428","issuer_name":"Axsome Therapeutics, Inc.","issuer_ticker":"AXSM","issuer_name_source":null,"issuer_url":"/issuer/0001579428","owner_cik":"0001658379","owner_name":"Coleman Mark","owner_url":"/insider/0001658379","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":161.11,"price_display":"161.11","price_state":"stated","total_value":4027750.0,"total_display":"4,027,750.00","shares_owned_after":47140.0,"shares_owned_after_display":"47,140","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-26","filed_date":"2026-02-27","scope":"insider"},{"id":4497459,"accession":"0000950170-25-113874","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000950170-25-113874","line_url":"/filing/0000950170-25-113874#line-3","is_derivative":false,"issuer_cik":"0001579428","issuer_name":"Axsome Therapeutics, Inc.","issuer_ticker":"AXSM","issuer_name_source":null,"issuer_url":"/issuer/0001579428","owner_cik":"0001658379","owner_name":"Coleman Mark","owner_url":"/insider/0001658379","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":800.0,"shares_display":"800","price_per_share":127.2,"price_display":"127.20","price_state":"stated","total_value":101760.0,"total_display":"101,760.00","shares_owned_after":47437.0,"shares_owned_after_display":"47,437","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-08","filed_date":"2025-09-09","scope":"insider"},{"id":4497450,"accession":"0000950170-25-113874","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-113874","line_url":"/filing/0000950170-25-113874#line-2","is_derivative":false,"issuer_cik":"0001579428","issuer_name":"Axsome Therapeutics, Inc.","issuer_ticker":"AXSM","issuer_name_source":null,"issuer_url":"/issuer/0001579428","owner_cik":"0001658379","owner_name":"Coleman Mark","owner_url":"/insider/0001658379","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":488.0,"shares_display":"488","price_per_share":127.4,"price_display":"127.40","price_state":"stated","total_value":62171.2,"total_display":"62,171.20","shares_owned_after":48212.0,"shares_owned_after_display":"48,212","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-08","filed_date":"2025-09-09","scope":"insider"},{"id":4497447,"accession":"0000950170-25-113874","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-113874","line_url":"/filing/0000950170-25-113874#line-1","is_derivative":false,"issuer_cik":"0001579428","issuer_name":"Axsome Therapeutics, Inc.","issuer_ticker":"AXSM","issuer_name_source":null,"issuer_url":"/issuer/0001579428","owner_cik":"0001658379","owner_name":"Coleman Mark","owner_url":"/insider/0001658379","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":287.0,"shares_display":"287","price_per_share":127.3,"price_display":"127.30","price_state":"stated","total_value":36535.1,"total_display":"36,535.10","shares_owned_after":47724.0,"shares_owned_after_display":"47,724","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-08","filed_date":"2025-09-09","scope":"insider"},{"id":4062750,"accession":"0000950170-25-079229","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-079229","line_url":"/filing/0000950170-25-079229#line-2","is_derivative":false,"issuer_cik":"0001579428","issuer_name":"Axsome Therapeutics, Inc.","issuer_ticker":"AXSM","issuer_name_source":null,"issuer_url":"/issuer/0001579428","owner_cik":"0001658379","owner_name":"Coleman Mark","owner_url":"/insider/0001658379","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3750.0,"shares_display":"3,750","price_per_share":103.43,"price_display":"103.43","price_state":"stated","total_value":387862.5,"total_display":"387,862.50","shares_owned_after":46637.0,"shares_owned_after_display":"46,637","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-28","filed_date":"2025-05-29","scope":"insider"},{"id":4062746,"accession":"0000950170-25-079229","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-079229","line_url":"/filing/0000950170-25-079229#line-1","is_derivative":false,"issuer_cik":"0001579428","issuer_name":"Axsome Therapeutics, Inc.","issuer_ticker":"AXSM","issuer_name_source":null,"issuer_url":"/issuer/0001579428","owner_cik":"0001658379","owner_name":"Coleman Mark","owner_url":"/insider/0001658379","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3750.0,"shares_display":"3,750","price_per_share":105.47,"price_display":"105.47","price_state":"stated","total_value":395512.5,"total_display":"395,512.50","shares_owned_after":50387.0,"shares_owned_after_display":"50,387","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-27","filed_date":"2025-05-29","scope":"insider"},{"id":4313223,"accession":"0000950170-25-075539","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-075539","line_url":"/filing/0000950170-25-075539#line-1","is_derivative":false,"issuer_cik":"0001579428","issuer_name":"Axsome Therapeutics, Inc.","issuer_ticker":"AXSM","issuer_name_source":null,"issuer_url":"/issuer/0001579428","owner_cik":"0001658379","owner_name":"Coleman Mark","owner_url":"/insider/0001658379","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":107.491,"price_display":"107.49","price_state":"stated","total_value":322473.0,"total_display":"322,473.00","shares_owned_after":54137.0,"shares_owned_after_display":"54,137","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-20","filed_date":"2025-05-20","scope":"insider"},{"id":3020705,"accession":"0000950170-24-066175","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-066175","line_url":"/filing/0000950170-24-066175#line-2","is_derivative":false,"issuer_cik":"0001579428","issuer_name":"Axsome Therapeutics, Inc.","issuer_ticker":"AXSM","issuer_name_source":null,"issuer_url":"/issuer/0001579428","owner_cik":"0001658379","owner_name":"Coleman Mark","owner_url":"/insider/0001658379","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5248.0,"shares_display":"5,248","price_per_share":75.1396,"price_display":"75.14","price_state":"stated","total_value":394332.6208,"total_display":"394,332.62","shares_owned_after":14600.0,"shares_owned_after_display":"14,600","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-29","filed_date":"2024-05-29","scope":"insider"},{"id":3020701,"accession":"0000950170-24-066175","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-066175","line_url":"/filing/0000950170-24-066175#line-1","is_derivative":false,"issuer_cik":"0001579428","issuer_name":"Axsome Therapeutics, Inc.","issuer_ticker":"AXSM","issuer_name_source":null,"issuer_url":"/issuer/0001579428","owner_cik":"0001658379","owner_name":"Coleman Mark","owner_url":"/insider/0001658379","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5249.0,"shares_display":"5,249","price_per_share":75.2095,"price_display":"75.21","price_state":"stated","total_value":394774.6655,"total_display":"394,774.67","shares_owned_after":19848.0,"shares_owned_after_display":"19,848","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-28","filed_date":"2024-05-29","scope":"insider"},{"id":7816504,"accession":"0001209191-23-049648","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-23-049648","line_url":"/filing/0001209191-23-049648#line-3","is_derivative":false,"issuer_cik":"0001579428","issuer_name":"Axsome Therapeutics, Inc.","issuer_ticker":"AXSM","issuer_name_source":null,"issuer_url":"/issuer/0001579428","owner_cik":"0001658379","owner_name":"Coleman Mark","owner_url":"/insider/0001658379","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18572.0,"shares_display":"18,572","price_per_share":75.1771,"price_display":"75.18","price_state":"stated","total_value":1396189.1012,"total_display":"1,396,189.10","shares_owned_after":403856.0,"shares_owned_after_display":"403,856","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-09-15","filed_date":"2023-09-15","scope":"insider"},{"id":7816501,"accession":"0001209191-23-049648","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-049648","line_url":"/filing/0001209191-23-049648#line-2","is_derivative":false,"issuer_cik":"0001579428","issuer_name":"Axsome Therapeutics, Inc.","issuer_ticker":"AXSM","issuer_name_source":null,"issuer_url":"/issuer/0001579428","owner_cik":"0001658379","owner_name":"Coleman Mark","owner_url":"/insider/0001658379","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11016.0,"shares_display":"11,016","price_per_share":75.1853,"price_display":"75.19","price_state":"stated","total_value":828241.2648,"total_display":"828,241.26","shares_owned_after":25097.0,"shares_owned_after_display":"25,097","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-15","filed_date":"2023-09-15","scope":"insider"},{"id":5261636,"accession":"0001209191-21-066004","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-066004","line_url":"/filing/0001209191-21-066004#line-2","is_derivative":false,"issuer_cik":"0001579428","issuer_name":"Axsome Therapeutics, Inc.","issuer_ticker":"AXSM","issuer_name_source":null,"issuer_url":"/issuer/0001579428","owner_cik":"0001658379","owner_name":"Coleman Mark","owner_url":"/insider/0001658379","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1021.0,"shares_display":"1,021","price_per_share":35.1,"price_display":"35.10","price_state":"stated","total_value":35837.1,"total_display":"35,837.10","shares_owned_after":422428.0,"shares_owned_after_display":"422,428","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-11-18","filed_date":"2021-11-22","scope":"insider"},{"id":5261633,"accession":"0001209191-21-066004","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-066004","line_url":"/filing/0001209191-21-066004#line-1","is_derivative":false,"issuer_cik":"0001579428","issuer_name":"Axsome Therapeutics, Inc.","issuer_ticker":"AXSM","issuer_name_source":null,"issuer_url":"/issuer/0001579428","owner_cik":"0001658379","owner_name":"Coleman Mark","owner_url":"/insider/0001658379","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":409.0,"shares_display":"409","price_per_share":35.07,"price_display":"35.07","price_state":"stated","total_value":14343.63,"total_display":"14,343.63","shares_owned_after":421407.0,"shares_owned_after_display":"421,407","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-11-18","filed_date":"2021-11-22","scope":"insider"},{"id":5333132,"accession":"0001209191-21-032250","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-032250","line_url":"/filing/0001209191-21-032250#line-1","is_derivative":false,"issuer_cik":"0001579428","issuer_name":"Axsome Therapeutics, Inc.","issuer_ticker":"AXSM","issuer_name_source":null,"issuer_url":"/issuer/0001579428","owner_cik":"0001658379","owner_name":"Coleman Mark","owner_url":"/insider/0001658379","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":58.15,"price_display":"58.15","price_state":"stated","total_value":29075.0,"total_display":"29,075.00","shares_owned_after":420998.0,"shares_owned_after_display":"420,998","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-05-12","filed_date":"2021-05-13","scope":"insider"},{"id":2105717,"accession":"0001104659-20-078441","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-20-078441","line_url":"/filing/0001104659-20-078441#line-1","is_derivative":false,"issuer_cik":"0001579428","issuer_name":"Axsome Therapeutics, Inc.","issuer_ticker":"AXSM","issuer_name_source":null,"issuer_url":"/issuer/0001579428","owner_cik":"0001658379","owner_name":"Coleman Mark","owner_url":"/insider/0001658379","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":650.0,"shares_display":"650","price_per_share":78.5,"price_display":"78.50","price_state":"stated","total_value":51025.0,"total_display":"51,025.00","shares_owned_after":403698.0,"shares_owned_after_display":"403,698","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-29","filed_date":"2020-06-30","scope":"insider"},{"id":7906628,"accession":"0001179110-19-008149","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-19-008149","line_url":"/filing/0001179110-19-008149#line-2","is_derivative":false,"issuer_cik":"0001579428","issuer_name":"Axsome Therapeutics, Inc.","issuer_ticker":"AXSM","issuer_name_source":null,"issuer_url":"/issuer/0001579428","owner_cik":"0001658379","owner_name":"Coleman Mark","owner_url":"/insider/0001658379","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15800.0,"shares_display":"15,800","price_per_share":23.1,"price_display":"23.10","price_state":"stated","total_value":364980.0,"total_display":"364,980.00","shares_owned_after":668848.0,"shares_owned_after_display":"668,848","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-06-26","filed_date":"2019-06-27","scope":"insider"},{"id":7906626,"accession":"0001179110-19-008149","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-19-008149","line_url":"/filing/0001179110-19-008149#line-1","is_derivative":false,"issuer_cik":"0001579428","issuer_name":"Axsome Therapeutics, Inc.","issuer_ticker":"AXSM","issuer_name_source":null,"issuer_url":"/issuer/0001579428","owner_cik":"0001658379","owner_name":"Coleman Mark","owner_url":"/insider/0001658379","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":400.0,"shares_display":"400","price_per_share":23.25,"price_display":"23.25","price_state":"stated","total_value":9300.0,"total_display":"9,300.00","shares_owned_after":653048.0,"shares_owned_after_display":"653,048","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-06-25","filed_date":"2019-06-27","scope":"insider"},{"id":8426519,"accession":"0001179110-19-006055","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-19-006055","line_url":"/filing/0001179110-19-006055#line-1","is_derivative":false,"issuer_cik":"0001579428","issuer_name":"Axsome Therapeutics, Inc.","issuer_ticker":"AXSM","issuer_name_source":null,"issuer_url":"/issuer/0001579428","owner_cik":"0001658379","owner_name":"Coleman Mark","owner_url":"/insider/0001658379","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4650.0,"shares_display":"4,650","price_per_share":21.44,"price_display":"21.44","price_state":"stated","total_value":99696.0,"total_display":"99,696.00","shares_owned_after":652648.0,"shares_owned_after_display":"652,648","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-13","filed_date":"2019-05-15","scope":"insider"},{"id":7912617,"accession":"0001104659-19-016423","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-19-016423","line_url":"/filing/0001104659-19-016423#line-1","is_derivative":false,"issuer_cik":"0001579428","issuer_name":"Axsome Therapeutics, Inc.","issuer_ticker":"AXSM","issuer_name_source":null,"issuer_url":"/issuer/0001579428","owner_cik":"0001658379","owner_name":"Coleman Mark","owner_url":"/insider/0001658379","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5100.0,"shares_display":"5,100","price_per_share":12.18,"price_display":"12.18","price_state":"stated","total_value":62118.0,"total_display":"62,118.00","shares_owned_after":5100.0,"shares_owned_after_display":"5,100","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-03-19","filed_date":"2019-03-21","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":23,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":11,"open_market":true},{"code":"S","label":"Open-market sale","n":12,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":23},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001579428","name":"Axsome Therapeutics, Inc.","url":"/issuer/0001579428","role":"Director","n_filings":14,"first_seen":"2019-03-21","last_seen":"2026-06-10"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001658379","retrieved_at":"2026-08-21T23:13:30+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}